🇺🇸 FDA
Pipeline program

A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.

2025ZSLYEC-365

Unknown small_molecule active

Quick answer

A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively. for Anal Fistula is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Anal Fistula
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials